KRISTEN ANDERSON: Open Payments
NPI 1891415758 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,325 in 148 payments from 14 companies in 2025. Trend: 2023 $928 · 2024 $1,127 · 2025 $2,325
Food & beverage: $2,325
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 19 | $293 |
| Otsuka America Pharmaceutical, Inc. | 14 | $264 |
| ABBVIE INC. | 16 | $247 |
| Janssen Pharmaceuticals, Inc | 14 | $225 |
| Axsome Therapeutics, Inc. | 12 | $222 |
| Neurocrine BioSciences, Inc. | 12 | $211 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $182 |
| Corium, LLC | 19 | $145 |
| Collegium Pharmaceutical, Inc. | 13 | $136 |
| Alkermes, Inc. | 5 | $111 |
Products named: FANAPT, REXULTI, VRAYLAR, Auvelity, INGREZZA, TRINTELLIX, Azstarys, Jornay PM.
Industry payments across WI — which companies pay providers there.
